Literature DB >> 33737645

Admission ECG changes predict short term-mortality after acute myocardial infarction less reliable in patients with diabetes.

Timo Schmitz1,2, Christian Thilo3, Jakob Linseisen4,5, Margit Heier6,7, Annette Peters7,8, Bernhard Kuch9, Christa Meisinger4,5.   

Abstract

Prior studies examined association between short-term mortality and certain changes in the admission ECG in acute myocardial infarction (AMI). Nevertheless, little is known about possible differences between patients with diabetes and without diabetes in this regard. So the aim of the study was to investigate the association between 28-day case fatality according to certain ECG changes comparing AMI cases with and without diabetes from the general population. From 2000 until 2017 a total of 9756 AMI cases was prospectively recorded in the study Area of Augsburg, Germany. Each case was assigned to one of the following groups according to admission ECG: 'ST-elevation', 'ST-depression', 'only T-negativity', 'predominantly bundle branch block', 'unspecific changes' and 'normal ECG' (the last two were put together for regression analyses). Multivariable adjusted logistic regression models were calculated to compare 28-day case-fatality between the ECG groups for the total sample and separately for diabetes and non-diabetes cases. For the non-diabetes group, the parsimonious logistic regression model revealed significantly better 28-day-outcome for the 'normal ECG / unspecific changes' group (OR: 0.47 [0.29-0.76]) compared to the reference group (STEMI). Contrary, in AMI cases with diabetes the category 'normal ECG / unspecific changes' was not significantly associated with lower short-term mortality (OR: 0.87 [0.49-1.54]). Neither of the other ECG groups was significantly associated with 28-day-mortality in the parsimonious logistic regression models. Consequently, the absence of AMI-typical changes in the admission ECG predicts favorable short-term mortality only in non-diabetic cases, but not so in patients with diabetes.

Entities:  

Year:  2021        PMID: 33737645     DOI: 10.1038/s41598-021-85674-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

1.  Early estimation of acute myocardial infarct size soon after coronary reperfusion using emission computed tomography with technetium-99m pyrophosphate.

Authors:  T Hashimoto; H Kambara; T Fudo; S Tamaki; R Nohara; Y Takatsu; R Hattori; S Tokunaga; C Kawai
Journal:  Am J Cardiol       Date:  1987-11-01       Impact factor: 2.778

2.  Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.

Authors:  David D McManus; Joel Gore; Jorge Yarzebski; Frederick Spencer; Darleen Lessard; Robert J Goldberg
Journal:  Am J Med       Date:  2011-01       Impact factor: 4.965

3.  Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).

Authors:  Tomotaka Dohi; Akiko Maehara; Sorin J Brener; Philippe Généreux; Anthony H Gershlick; Roxana Mehran; C Michael Gibson; Gary S Mintz; Gregg W Stone
Journal:  Am J Cardiol       Date:  2014-12-18       Impact factor: 2.778

4.  Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines.

Authors:  Chee Tang Chin; Tracy Y Wang; Shuang Li; Stephen D Wiviott; James A deLemos; Michael C Kontos; Eric D Peterson; Matthew T Roe
Journal:  Clin Cardiol       Date:  2012-03-20       Impact factor: 2.882

5.  Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.

Authors:  P W Armstrong; Y Fu; W C Chang; E J Topol; C B Granger; A Betriu; F Van de Werf; K L Lee; R M Califf
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690

6.  Usefulness of ST depression with T-wave inversion in leads V(4) to V(6) for predicting one-year mortality in non-ST-elevation acute coronary syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial).

Authors:  Shaul Atar; Yuling Fu; Galen S Wagner; Salvatore Rosanio; Alejandro Barbagelata; Yochai Birnbaum
Journal:  Am J Cardiol       Date:  2007-02-15       Impact factor: 2.778

7.  Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).

Authors:  J Dawn Abbott; Hanna N Ahmed; Helen A Vlachos; Faith Selzer; David O Williams
Journal:  Am J Cardiol       Date:  2007-06-04       Impact factor: 2.778

8.  STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry).

Authors:  Gilles Montalescot; Jean Dallongeville; Eric Van Belle; Stephanie Rouanet; Cathrine Baulac; Alexia Degrandsart; Eric Vicaut
Journal:  Eur Heart J       Date:  2007-04-05       Impact factor: 29.983

9.  Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Authors:  Stanley Chia; Fred Senatore; O Christopher Raffel; Hang Lee; Frans J Th Wackers; Ik-Kyung Jang
Journal:  JACC Cardiovasc Interv       Date:  2008-08       Impact factor: 11.195

10.  Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction - a prospective CMR study.

Authors:  Pauli Pöyhönen; Minna Kylmälä; Paula Vesterinen; Sari Kivistö; Miia Holmström; Kirsi Lauerma; Heikki Väänänen; Lauri Toivonen; Helena Hänninen
Journal:  BMC Cardiovasc Disord       Date:  2018-02-08       Impact factor: 2.298

View more
  3 in total

Review 1.  Neuroinflammation Involved in Diabetes-Related Pain and Itch.

Authors:  Xiao-Xia Fang; Heng Wang; Hao-Lin Song; Juan Wang; Zhi-Jun Zhang
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

2.  Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction.

Authors:  Zhenying Zhang; Xiaojing Sun; Jiagui Ma; Qiaoyan Ma; Qian Cao; Liu Zhang; Lizhong Wang
Journal:  Comput Math Methods Med       Date:  2022-04-18       Impact factor: 2.809

3.  Correlation between Glycated Haemoglobin Level, Cardiac Function, and Prognosis in Patients with Diabetes Mellitus Combined with Myocardial Infarction.

Authors:  Guangwei Zeng; Huixian An; Wei Li; Dong Fang; Mengna Sun; Qiangsun Zheng
Journal:  Dis Markers       Date:  2022-09-23       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.